Categories  |  Inventors

Technology Overview

OHSU # 1991 — T2* Mapping for quantitative assessment of placental function and oxygenation

Despite recent focus, including the announcement of the NIH Human Placenta Project, on placental health and function as a primary driver of fetal growth and development, current in vivo identification and assessment of abnormal placentation is limited. This MRI protocol and modeling methodology, which uses an endogeneous contrast agent and therefore is non-invasive, facilitates assessment of oxygenation and blood flow in the placenta. This technique could be used in pregnancies complicated by preeclampsia, preterm labor, intrauterine growth restriction, diabetes mellitus, chronic hypertension and other high risk conditions associated with abnormal placentation.

Inventors:

Patents

Published United States WO 2017/053799
Issued United States 10,835,159

Categories:

For more information, contact:

Trina Voss
Technology Development Manager
503-494-9839